Formosa Laboratories, Inc. (TPE:4746)
54.40
-0.90 (-1.63%)
At close: Mar 26, 2026
Formosa Laboratories Revenue
In the year 2025, Formosa Laboratories had annual revenue of 4.85B TWD with 2.54% growth. Formosa Laboratories had revenue of 1.30B in the quarter ending December 31, 2025, a decrease of -3.50%.
Revenue
4.85B
Revenue Growth
+2.54%
P/S Ratio
1.35
Revenue / Employee
17.33M
Employees
280
Market Cap
6.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.85B | 120.31M | 2.54% |
| Dec 31, 2024 | 4.73B | 370.60M | 8.50% |
| Dec 31, 2023 | 4.36B | 594.94M | 15.80% |
| Dec 31, 2022 | 3.77B | 623.10M | 19.83% |
| Dec 31, 2021 | 3.14B | 66.95M | 2.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 7.02B |
| Orient EuroPharma | 4.60B |
| Handa Pharmaceuticals | 1.62B |
| Orient Pharma | 1.40B |
| SCI Pharmtech | 1.34B |
| Easywell Biomedicals | 597.41M |
| Foresee Pharmaceuticals | 431.27M |